Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Gains from Sales and Divestitures (2021 - 2025)

Historic Gains from Sales and Divestitures for AVITA Medical (RCEL) over the last 5 years, with Q3 2025 value amounting to $109180.0.

  • AVITA Medical's Gains from Sales and Divestitures fell 2075.43% to $109180.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $109180.0, marking a year-over-year decrease of 2075.43%. This contributed to the annual value of $235059.0 for FY2023, which is 7731.2% up from last year.
  • AVITA Medical's Gains from Sales and Divestitures amounted to $109180.0 in Q3 2025, which was down 2075.43% from $76724.0 recorded in Q2 2025.
  • In the past 5 years, AVITA Medical's Gains from Sales and Divestitures ranged from a high of $235059.0 in Q4 2023 and a low of $14608.0 during Q1 2025
  • For the 5-year period, AVITA Medical's Gains from Sales and Divestitures averaged around $103913.5, with its median value being $92650.0 (2023).
  • Within the past 5 years, the most significant YoY rise in AVITA Medical's Gains from Sales and Divestitures was 26528.48% (2022), while the steepest drop was 6126.27% (2022).
  • AVITA Medical's Gains from Sales and Divestitures (Quarter) stood at $28754.0 in 2021, then skyrocketed by 361.04% to $132568.0 in 2022, then soared by 77.31% to $235059.0 in 2023, then tumbled by 41.39% to $137774.0 in 2024, then dropped by 20.75% to $109180.0 in 2025.
  • Its Gains from Sales and Divestitures was $109180.0 in Q3 2025, compared to $76724.0 in Q2 2025 and $14608.0 in Q1 2025.